For tapentadol, only two of the three randomized managed trials performed to this point in diabetic peripheral neuropathy have concluded that tapentadol is outstanding to placebo [sixty four, seventy two]. On The premise in the accessible facts, its efficacy During this sign was regarded inferior to that of tramadol, and doubtless overestimated by